Epidemiological and clinical characteristics of 5,628 patients with coronavirus disease 2019 in South Korea: A nationwide multicenter study

IF 0.2 Q4 ALLERGY

Allergy, Asthma & Respiratory Disease Pub Date : 2021-07-01 DOI:10.4168/aard.2021.9.3.136

Seung Won Lee, S. Moon, D. Yon

{"title":"Epidemiological and clinical characteristics of 5,628 patients with coronavirus disease 2019 in South Korea: A nationwide multicenter study","authors":"Seung Won Lee, S. Moon, D. Yon","doi":"10.4168/aard.2021.9.3.136","DOIUrl":null,"url":null,"abstract":"Purpose: There are limited data on the epidemiological and clinical characteristics and outcomes in Korean patients with labora\u001ftory-confirmed coronavirus disease 2019 (COVID-19). We aimed to describe the epidemiological and clinical characteristics and out\u001fcomes of patients with COVID-19 using the Korean nationwide multicenter database.\nMethods: In this nationwide multicenter study, we included all confirmed patients of COVID-19 in South Korea from February 1 to April 30, 2020. Subjects were classified into 3 age groups: those at younger than 10 years (children), 10 to 20 years (adolescents), and 20 years or more (adults). Cases were confirmed by laboratory testing using real-time reverse transcriptase-polymerase chain reac\u001ftion assay and analyzed for epidemiological and clinical features and outcomes. Patents were followed up until April 30, 2020.\nResults: Of 5,628 patients with COVID-19 (2,320 males [41.2%] and 3,308 females [58.8%]), there were 66 children (1.2%), 206 ado\u001flescents (3.7%), and 5,356 adults (95.2%). The common comorbidities were hypertension (1,201, 21.3%), diabetes (691, 12.3%), de\u001fmentia (224, 4.0%), chronic heart disease (179, 3.2%), cancer (145, 2.6%), and asthma (128, 2.3%). The common presenting symp\u001ftoms were cough (2,341, 41.6%), sputum (1,619, 28.8%), fever (1,305, 23.2%), headache (967, 17.2%), myalgia (926, 16.5%), and pha\u001fryngodynia (881, 15.7%). One hundred sixty-five patients (2.1%) were confirmed as having moderate or severe COVID-19 and 118 (2.1%) as having severe COVID-19.\nConclusion: Our descriptive study provides the epidemiological and clinical characteristics and outcomes of patients with labora\u001ftory-confirmed COVID-19 in South Korea. (Allergy Asthma Respir Dis 2021;9:136-140)","PeriodicalId":7548,"journal":{"name":"Allergy, Asthma & Respiratory Disease","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy, Asthma & Respiratory Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4168/aard.2021.9.3.136","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 3

Abstract

Purpose: There are limited data on the epidemiological and clinical characteristics and outcomes in Korean patients with laboratory-confirmed coronavirus disease 2019 (COVID-19). We aimed to describe the epidemiological and clinical characteristics and outcomes of patients with COVID-19 using the Korean nationwide multicenter database. Methods: In this nationwide multicenter study, we included all confirmed patients of COVID-19 in South Korea from February 1 to April 30, 2020. Subjects were classified into 3 age groups: those at younger than 10 years (children), 10 to 20 years (adolescents), and 20 years or more (adults). Cases were confirmed by laboratory testing using real-time reverse transcriptase-polymerase chain reaction assay and analyzed for epidemiological and clinical features and outcomes. Patents were followed up until April 30, 2020. Results: Of 5,628 patients with COVID-19 (2,320 males [41.2%] and 3,308 females [58.8%]), there were 66 children (1.2%), 206 adolescents (3.7%), and 5,356 adults (95.2%). The common comorbidities were hypertension (1,201, 21.3%), diabetes (691, 12.3%), dementia (224, 4.0%), chronic heart disease (179, 3.2%), cancer (145, 2.6%), and asthma (128, 2.3%). The common presenting symptoms were cough (2,341, 41.6%), sputum (1,619, 28.8%), fever (1,305, 23.2%), headache (967, 17.2%), myalgia (926, 16.5%), and pharyngodynia (881, 15.7%). One hundred sixty-five patients (2.1%) were confirmed as having moderate or severe COVID-19 and 118 (2.1%) as having severe COVID-19. Conclusion: Our descriptive study provides the epidemiological and clinical characteristics and outcomes of patients with laboratory-confirmed COVID-19 in South Korea. (Allergy Asthma Respir Dis 2021;9:136-140)

查看原文本刊更多论文

韩国2019年5628例冠状病毒病患者的流行病学和临床特征:一项全国性多中心研究

目的:韩国实验室确诊的冠状病毒病2019 (COVID-19)患者的流行病学、临床特征和结局数据有限。我们的目的是利用韩国全国多中心数据库描述COVID-19患者的流行病学和临床特征以及结果。方法:在这项全国性的多中心研究中，我们纳入了2020年2月1日至4月30日在韩国确诊的所有COVID-19患者。研究对象分为3个年龄组:10岁以下(儿童)、10 ~ 20岁(青少年)和20岁及以上(成人)。采用实时逆转录-聚合酶链反应实验室检测确诊病例，分析流行病学和临床特征及转归。专利被跟踪到2020年4月30日。结果:5628例新冠肺炎患者中，男性2320例(41.2%)，女性3308例(58.8%)，其中儿童66例(1.2%)，青少年206例(3.7%)，成人5356例(95.2%)。常见合并症为高血压(1201例，21.3%)、糖尿病(691例，12.3%)、肺心病(224例，4.0%)、慢性心脏病(179例，3.2%)、癌症(145例，2.6%)、哮喘(128例，2.3%)。常见症状为咳嗽2341例(41.6%)、咳痰1619例(28.8%)、发热1305例(23.2%)、头痛967例(17.2%)、肌痛926例(16.5%)、舌痛881例(15.7%)。确诊为中重度165例(2.1%)，确诊为重度118例(2.1%)。结论:我们的描述性研究提供了韩国实验室确诊的COVID-19患者的流行病学、临床特征和结局。(过敏哮喘呼吸疾病2021;9:36 -140)

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergy, Asthma & Respiratory Disease ALLERGY-

自引率

0.00%

发文量